ASTRAZENECA PLC AZN

Latest FY: 2025 Healthcare Drug Manufacturers - General
Market Price $156.44
Market Cap $243.82B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑8.6% YoY
$58.74B
3-Yr CAGR: 9.8%
Net Income ↑33.3% YoY
$8.00M
Net Margin: 0.0%
Free Cash Flow ↓-144.5% YoY
-$1.49B
FCF Yield: -0.61%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
0.0%
ROA: 0.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AZN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $23,002.0M $18,876.0M $-93.0M $677.0M $-769.0M
FY 2017 $22,465.0M -2.3% $18,147.0M $-133.0M -43.0% $698.0M $-628.0M +18.3%
FY 2018 $22,090.0M -1.7% $17,154.0M $-105.0M +21.1% $676.0M $-367.0M +41.6%
FY 2019 $24,384.0M +10.4% $19,463.0M $-108.0M -2.9% $774.0M $-205.0M +44.1%
FY 2020 $26,617.0M +9.2% $21,318.0M $-52.0M +51.9% $733.0M $-228.0M -11.2%
FY 2021 $37,417.0M +40.6% $24,980.0M $3.0M +105.8% $721.0M $-370.0M -62.3%
FY 2022 $44,351.0M +18.5% $31,960.0M $5.0M +66.7% $849.0M $-242.0M +34.6%
FY 2023 $45,811.0M +3.3% $37,543.0M $6.0M +20.0% $1,081.0M $-280.0M -15.7%
FY 2024 $54,073.0M +18.0% $43,866.0M $6.0M 0.0% $1,313.0M $-611.0M -118.2%
FY 2025 $58,739.0M +8.6% $48,106.0M $8.0M +33.3% $1,316.0M $-1,494.0M -144.5%
$

Valuation

Market Price $156.44
Market Cap $243.82B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 4.98
FCF Yield -0.61%
Dividend Yield N/A
Shares Outstanding 1,550,848,100
%

Profitability & Margins

Gross Margin 81.90%
Operating Margin 23.40%
Net Margin 0.01%
Return on Equity (ROE) 0.02%
Return on Assets (ROA) 0.01%
Asset Turnover 0.51x
Revenue 3-Yr CAGR 9.82%
🛡️

Financial Health & Liquidity

Current Ratio 1.07
Cash Ratio 5.27
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $5.71B
Total Debt N/A
Book Value / Share $31.41
💧

Cash Flow Efficiency

Operating Cash Flow $1.32B
Capital Expenditures (CapEx) $2.81B
Free Cash Flow -$1.49B
OCF / Revenue 2.24%
FCF / Revenue -2.54%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $31.41
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $114.07B
Total Liabilities $65.36B
Stockholders' Equity $48.72B
Current Assets $1.16B
Current Liabilities $1.08B